Predictors of failure of fish-oil therapy for intestinal failure–associated liver disease in children(1)(2)

Background: Parenteral fish-oil (FO) therapy is a safe and effective treatment for intestinal failure–associated liver disease (IFALD). Patients whose cholestasis does not resolve with FO may progress to end-stage liver disease. Objective: We sought to identify factors associated with the failure of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Clin Nutr
Asıl Yazarlar: Nandivada, Prathima, Baker, Meredith A, Mitchell, Paul D, O’Loughlin, Alison A, Potemkin, Alexis K, Anez-Bustillos, Lorenzo, Carlson, Sarah J, Dao, Duy T, Fell, Gillian L, Gura, Kathleen M, Puder, Mark
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Nutrition 2016
Konular:
Digestive and Liver Diseases
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997303/
https://ncbi.nlm.nih.gov/pubmed/27510535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3945/ajcn.116.137083
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller